Regular Paper
Prognostic variables in patients with cirrhosis and oesophageal varices without prior bleeding

https://doi.org/10.1016/S0168-8278(05)80599-9Get rights and content

As identification of patients at risk of bleeding or death is essential for prophylaxis, we determined the prognostic influence of various patient characteristics on the risk of bleeding and death. Fifty-five patients with cirrhosis and oesophageal varices without previous bleeding were included in the study and followed up after an average observation period of 446 days (range: 5–1211 days). A total of 55 clinical, biochemical, haemodynamic, and endoscopic variables were classified as systemic haemodynamic, portal haemodynamic, or metabolic. Using univariate analysis, the following variables showed a significant relation with an increased risk of bleeding or death: high plasma volume (p<0.02), high azygos blood flow (p<0.004), elevated hepatic venous pressure gradient (p<0.02), marked prominence of varices (p<0.05), poor nutritional status (p<0.0001), decreased clotting factor 2,7,10 (p<0.002), poor incapacitation index (p<0.004), low serum albumin (p<0.005), increased serum bilirubin (p=0.05), elevated alkaline phosphatases (p<0.02), low arterial oxygen saturation (p=0.02), and encephalopathy (p<0.007). In a Cox regression model, poor nutritional status (p<0.00005), increased serum bilirubin (p<0.001), short central circulation time (p<0.03), low serum albumin (p<0.02), and decreased clotting factor 2,7,10 (p<0.05) were independently associated with a higher risk. In conclusion, the results support the prognostic value of metabolic variables as described earlier. The prognostic significance of central circulation time stresses the importance of the hyperdynamic systemic circulation in assessing the increased risk of bleeding or death. Assessment of the haemodynamic status in cirrhosis may provide additional prognostic information and be helpful in the selection of patients for prophylaxis.

References (50)

  • MerkelC et al.

    Can we predict the first variceal bleeding in the individual patient with cirrhosis and esophageal varices

    J Hepatol

    (1991)
  • de FranchisR et al.
  • GroszmannRJ et al.

    Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage

    Gastroenterology

    (1990)
  • LebrecD et al.

    Portal hypertension, size of esophageal varices, and risk of gastrointestinal bleeding in alcoholic cirrhosis

    Gastroenterology

    (1980)
  • KoshyA et al.

    Effects of oxygen inhalation on tissue oxygenation in patients with cirrhosis

    J Hepatol

    (1989)
  • VallaD et al.

    Failure of haemodynamic measurements to predict recurrent gastrointestinal bleeding in cirrhotic patients receiving propranolol

    J Hepatol

    (1987)
  • PagliaroL et al.

    Prevention of first bleeding in cirrhosis. A metaanalysis of randomized trials of non-surgical treatment

    Ann Intern Med

    (1992)
  • AndreaniT et al.

    Preventive therapy of first gastrointestinal bleeding in patients with cirrhosis: results of a controlled trial comparing propranolol, endoscopic sclerotherapy and placebo

    Hepatology

    (1990)
  • PoynardT et al.

    Beta-adrenergic-antagonist drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices. An analysis of data and prognostic factors in 589 patients from four randomized clinical trials

    N Engl J Med

    (1991)
  • Prophylaxis of first hemorrhage from esophageal varices by sclerotherapy, propranolol or both in cirrhotic patients: a randomized multicenter trial

    Hepatology

    (1991)
  • Garcia-TsaoG et al.

    Portal pressure, presence of gastroesophageal varices and variceal bleeding

    Hepatology

    (1985)
  • The North Italian Endoscopic Club for the Study and Treatment of Esophageal Varices

    Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. A prospective multicenter study

    N Engl J Med

    (1988)
  • MerkelC et al.

    Prognostic indicators of survival in patients with cirrhosis and esophageal varices, without previous bleeding

    Am J Gastroenterol

    (1989)
  • GluudC et al.

    Prognostic indicators in alcoholic cirrhotic men

    Hepatology

    (1988)
  • CroweJ et al.

    Azathioprine in primary biliary cirrhosis. A preliminary report of an international trial

    Gastroenterology

    (1980)
  • Cited by (82)

    • Hepatobiliary Quiz Answers – 18 (2016)

      2016, Journal of Clinical and Experimental Hepatology
      Citation Excerpt :

      Cirrhotic patients who are malnourished are more likely to have portal hypertension, portosystemic collaterals, and varices. They also have more severe portal hypertension and higher risk of variceal bleeding.60 Most of our body proteins are located in the skeletal muscle, thus, adult protein malnutrition is primarily defined as skeletal muscle loss.

    • Nutrition in Chronic Liver Disease

      2015, GE Portuguese Journal of Gastroenterology
    • HVPG as a Gold Standard: Accuracy Is Essential

      2022, Portal Hypertension VII: Proceedings of the 7th Baveno Consensus Workshop: Personalized Care in Portal Hypertension
    View all citing articles on Scopus
    View full text